Head-to-head · WeighScore
Intimate Rose vs ShedRx
The verdict
ShedRx takes it — 87/100 to 65.1/100.
ShedRx grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. The widest formulation spread in the ranking — injection, drops, lozenges and a daily oral pill, plus a real brand Zepbound lane.
We may earn a commission through these links, at no extra cost to you. Commercial relationships affect placement, but never the WeighScore or our editorial findings. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Intimate Rose | ShedRx |
|---|---|---|
| WeighScore | 65.1/100 | 87/100 |
| Grade | C | B+ |
| Site position | #253 | #3 |
| Semaglutide | $169/mo (all doses, compounded) | $199/mo |
| Tirzepatide | $169/mo (all doses, compounded) | $299/mo |
| Coverage | Coverage not published | All 50 states |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Site position #253 · C
FDAWarning letter issued to Intimate Rose in September 2025. See the FDA warning-letter database.
Strengths
- Transparent pricing from 169 dollars per month shown upfront, not gated behind intake
- Medication and free delivery included, HSA and FSA eligible, no contract
- Backed by an established women's-health brand using the OpenLoop provider network
Where it loses points
- State availability not published
- Oral compounded GLP-1 only; no injectable option shown
- No specific compounding pharmacy named (network fulfillment via OpenLoop)
- FDA issued Intimate Rose a warning letter in September 2025; the letter is public in FDA's warning-letter database
Site position #3 · B+
Strengths
- Four GLP-1 routes — injection, liquid drops, lozenges and an oral daily pill
- Brand Zepbound and Wegovy available beside the compounded line
- Health coaching included with membership, plus a published 120-day weight-loss guarantee
Where it loses points
- The advertised "as low as $239" tirzepatide rate requires a twelve-month commitment — month-to-month is $299
- Compounded medication is not FDA-approved the way brand Ozempic, Wegovy, or Zepbound are
- The dispensing compounding pharmacy is not publicly named
Featured provider
ShedRx
ShedRx scores 87/100 (B+). The widest formulation spread in the ranking — injection, drops, lozenges and a daily oral pill, plus a real brand Zepbound lane.
Commercial relationships affect this placement. The score comparison above is separate.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.